|
The reason for this revision surgery was reported as subsidence on stem.The previous surgery and the surgery detailed in this event occurred 3 years and 9 months apart.The healthcare professional indicated there was a serious risk event to the patient.There was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at hospital and not made available to djo surgical for examination.A review of the device history record (dhr) shows that the reported component used in the previous surgery, when released for use, met design and manufacturing requirements.At first, there was an ncmr-35132 associated with the main part #495-16-210 exprt revision hip, distal stem, 16x210 which documents that out of 26 parts lot, all parts were rejected due to product packaged requires new ifu inserted into packaging.Later the rejected parts were reworked and accepted after proper justification.Secondly, there was an ncmr-35658 associated with the same part which documents that out of 26 parts lot, all parts were rejected due to improper packaging.Later the rejected parts were reworked and accepted after proper justification.The device was verified to have gone through an acceptable sterilization process and was within its date at the time of the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are needing a review.The root cause of this complaint was a revision surgery due to subsidence on stem.There were no findings during this evaluation that indicate the reported device was defective.No information was submitted with the complaint regarding pre-existing conditions of the patient or any activities the patient was involved in that may have contributed to the event.There are multiple factors that may also contribute to an event that are outside the control of djo surgical such as poor bone density, patient bone deterioration, inadequate soft tissue support, patient activities or trauma.There are no indications of a product or process issue affecting implant safety or effectiveness.Additional reporting on this event will be provided as a supplemental report to this document if it becomes available.
|